Key result
Combination antihypertensives outperform monotherapy for BP control via multiple mechanisms and lower drug doses.
Why the study?
Raised blood pressure is a common complication linked to atherosclerosis and ischemic heart disease, warranting an overview of monotherapy versus multi-mechanism combination therapy approaches.
Does combination antihypertensive therapy improve blood pressure management and reduce cardiovascular disease risks compared to monotherapy in patients with hypertension?
Does combination antihypertensive therapy improve blood pressure management and reduce cardiovascular disease risks compared to monotherapy in patients with hypertension?
Combination antihypertensive therapy offers mechanistic advantages and requires lower drug doses compared to monotherapy for effective blood pressure management.
Answers are grounded in this paper and cite their sources.
Supports mechanistic advantages of combination therapy; leaves open impact on cardiovascular outcomes from RCTs.
Raised blood pressure is the most common complication worldwide that may lead to atherosclerosis and ischemic heart disease. Unhealthy lifestyles, smoking, alcohol consumption, junk food, and genetic disorders are some of the causes of hypertension. To treat this condition, numerous antihypertensive medications are available, either alone or in combination, that work via various mechanisms of action. Combinational therapy provides a certain advantage over monotherapy in the sense that it acts in multi mechanism mode and minimal drug amount is required to elicit the desired therapeutic effect. Such therapy is given to patients with systolic blood pressure greater than 20 mmHg and/or diastolic blood pressure exceeding 10 mmHg beyond the normal range, as well as those suffering from severe cardiovascular disease. The selection of antihypertensive medications, such as calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and low-dose diuretics, hinges on their ability to manage blood pressure effectively and reduce cardiovascular disease risks. This review provides insights into the diverse monotherapy and combination therapy approaches used for elevated blood pressure management. In addition, it offers an analysis of combination therapy versus monotherapy and discusses the current status of these therapies, from researchbased findings to clinical trials.
No takes yet. Share an insight, caveat, or question.
Niranjan et al. (2023) conducted a review in Hypertension. Combination antihypertensive therapy vs. Monotherapy was evaluated. Combination antihypertensive therapy provides advantages over monotherapy by acting via multiple mechanisms and requiring minimal drug amounts to manage elevated blood pressure effectively.
Synapse has enriched 10 related papers. Consider them for comparative context: